The Relative Bioavailability and Single-Dose Pharmacokinetics of a Novel Extended-Release Chewable Tablet of Methylphenidate Compared With Immediate-Release Methylphenidate Chewable Tablet in Healthy Volunteers

New Research Poster Presentation 6.32
The Relative Bioavailability and Single-Dose Pharmacokinetics of a Novel Extended-Release Chewable Tablet of Methylphenidate Compared With Immediate-Release Methylphenidate Chewable Tablet in Healthy Volunteers

Saturday, October 31, 2015 10:00 AM

Richat Abbas, PhD, Pfizer, Inc., New York, NY

Donna Palumbo, PhD, Medical Affairs, Global Established Products, Pfizer, Inc., New York, NY

Faith Walters, PharmD, Medical Affairs, Global Established Products, Pfizer, Inc., New York, NY

Heidi Belden, PharmD, Pfizer, Inc., Plymouth, MA

Sally Berry, MD, PhD, NextWave Pharmaceuticals, Titusville, NJ